TotalMarketCap

Calidi Biotherapeutics

CLDINYSE United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$2.322 M

$0.63 -13.69%

Close of 6 Nov 2026

As of 6 Nov 2026, Calidi Biotherapeutics (CLDI) has a market capitalization of $2.32M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$19.9M

Loss-making

Shares outstanding

2,584,184

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #159Tessera Defense & Homeland SecurityHLSQ$3.22M
  2. #160VivoSim LabsVIVS$2.41M
  3. #161Calidi BiotherapeuticsCLDI$2.32M
  4. #162Silexion TherapeuticsSLXN$2.19M
  5. #163Scinai ImmunotherapeuticsSCNI$1.21M

What if Calidi Biotherapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$7,660,887

Per share 12,160,138× higher

Bitcoin $1.53T

$414,517.25

Per share 657,964× higher

Apple $5.02T

$1,360,821

Per share 2,160,034× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Calidi Biotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.